Briefs

InforSense Partners with the U.K.'s South London and Maudsley NHS Foundation Trust and King�s College London to Combat Alzheimer�s Disease

Translational Research Solution to Help Accelerate Early Diagnosis and Personalized Medicine Treatments

London, UK and Cambridge, MA, December 2, 2008 � InforSense Ltd., the leading provider of next generation business and scientific intelligence tools, today announced that the National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at the South London and Maudsley National Health Service (NHS) Foundation Trust (SLaM) and Institute of Psychiatry, King's College London will use InforSense's translational research tools in Alzheimer's disease studies to advance the development of early diagnostic tools and develop personalized medicine treatments within mental health research. For the first time, informaticians, researchers and clinicians will be able to directly access their entire patient and 'omics' data through a common data analysis platform. The InforSense solution will eliminate errors associated with manual data processes and bottlenecks relating to data access and analysis by non-specialist end users.

For more information visit www.inforsense.com and on Twitter at http://twitter.com/InforSense.